Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (74)
Glucagon-like peptide 1 (GLP-1) receptor agonists use during pregnancy: Safety data from regulatory clinical trials
J.ZhangY
Comparing injection vs
US$ 26.26
US$ 21.21
US$ 25.64
US$ 25.13
US$ 22.90
US$ 26.88
